{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T04:17:18Z","timestamp":1749097038273,"version":"3.41.0"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:title>ABSTRACT:<\/jats:title>\n          <jats:p>Gastrointestinal (GI) disorders range from intermittent heartburn to life-threatening GI hemorrhage. One of the most common GI disorders is gastroesophageal reflux disease (GERD), which affects an estimated 19% of adults in North America. This article discusses the advantages and disadvantages of acid-suppressive therapy for patients with GERD as well as relevant nursing considerations.<\/jats:p>","DOI":"10.1097\/nsg.0000000000000065","type":"journal-article","created":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T04:00:33Z","timestamp":1729224033000},"page":"40-43","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Acid suppressive therapy for gastroesophageal reflux disease"],"prefix":"10.1097","volume":"54","author":[{"given":"Avery","family":"Ballinger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"Letsa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Sheridan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,10,18]]},"reference":[{"issue":"3","key":"R1-20250604","doi-asserted-by":"crossref","DOI":"10.1177\/03000605221086457","article-title":"Antacids revisited: review on contemporary facts and relevance for self-management","volume":"50","author":"Garg","year":"2022","journal-title":"J Int Med Res"},{"issue":"5","key":"R2-20250604","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.cgh.2022.01.025","article-title":"AGA clinical practice update on the personalized approach to the evaluation and management of GERD: expert review","volume":"20","author":"Yadlapati","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"R3-20250604","doi-asserted-by":"crossref","first-page":"27","DOI":"10.14309\/ajg.0000000000001538","article-title":"ACG clinical guideline for the diagnosis and management of gastroesophageal reflux disease","volume":"117","author":"Katz","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"R4-20250604","doi-asserted-by":"crossref","first-page":"l6744","DOI":"10.1136\/bmj.l6744","article-title":"Efficacy and safety of gastrointestinal bleeding prophylaxis in critically ill patients: systematic review and network meta-analysis","volume":"368","author":"Wang","year":"2020","journal-title":"BMJ"},{"issue":"1","key":"R5-20250604","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mcna.2018.08.001","article-title":"Proton pump inhibitors: what the internist needs to know","volume":"103","author":"Spechler","year":"2019","journal-title":"Med Clin North Am"},{"key":"R6-20250604","first-page":"10","article-title":"The risks of long-term use of proton pump inhibitors: a critical review","author":"Jaynes","year":"2018","journal-title":"Ther Adv Drug Saf"},{"issue":"1","key":"R7-20250604","doi-asserted-by":"crossref","first-page":"21169","DOI":"10.1038\/s41598-023-48430-9","article-title":"Proton pump inhibitors and chronic kidney disease risk: a comparative study with histamine-2 receptor antagonists","volume":"13","author":"Kweon","year":"2023","journal-title":"Sci Rep"},{"issue":"18","key":"R8-20250604","doi-asserted-by":"crossref","first-page":"e1771","DOI":"10.1212\/WNL.0000000000207747","article-title":"Cumulative use of proton pump inhibitors and risk of dementia: The Atherosclerosis Risk in Communities Study","volume":"101","author":"Northuis","year":"2023","journal-title":"Neurology"},{"issue":"4","key":"R9-20250604","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s40262-019-00844-3","article-title":"A systematic review of gastric acid-reducing agent-mediated drug-drug interactions with orally administered medications","volume":"59","author":"Patel","year":"2020","journal-title":"Clin Pharmacokinet"}],"container-title":["Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/NSG.0000000000000065","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T22:00:57Z","timestamp":1749074457000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/NSG.0000000000000065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,18]]},"references-count":9,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/nsg.0000000000000065","relation":{},"ISSN":["0360-4039","1538-8689"],"issn-type":[{"type":"print","value":"0360-4039"},{"type":"electronic","value":"1538-8689"}],"subject":[],"published":{"date-parts":[[2024,10,18]]}}}